AI Summary
We reviewed 39 live results for tnf inhibitors and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Tnf Inhibitors.
Comparison Table
Recommended
Hulio
Source: Viatris / Fujifilm Kyowa Kirin Biologics
Description
Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis.
Best for
immune-mediated disorders, Singapore NDF access and subcutaneous administration
View Details
Rating
Abrilada
Source: Pfizer Private Limited
Description
Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases.
Best for
biologic therapy, chronic inflammation management and subcutaneous injection
View Details
Rating
Amgevita
Source: Amgen Biotechnology Singapore Pte Ltd
Description
Amgevita is a biosimilar adalimumab injection available as a solution in pre-filled autoinjectors and syringes. It is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis and plaque psoriasis. As of 2025, it includes high-concentration formulations (20mg/0.2ml and 40mg/0.4ml) and is eligible for government subsidies in Singapore under the Ministry of Health (MOH) Standard Drug List.
Best for
government subsidy eligibility, rheumatoid arthritis, high-concentration formulation and standard drug list access
View Details
Rating
| Compare | Hulio | Abrilada | Amgevita |
|---|---|---|---|
| Source | Viatris / Fujifilm Kyowa Kirin Biologics | Pfizer Private Limited | Amgen Biotechnology Singapore Pte Ltd |
| Description | Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis. | Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases. | Amgevita is a biosimilar adalimumab injection available as a solution in pre-filled autoinjectors and syringes. It is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis and plaque psoriasis. As of 2025, it includes high-concentration formulations (20mg/0.2ml and 40mg/0.4ml) and is eligible for government subsidies in Singapore under the Ministry of Health (MOH) Standard Drug List. |
| Best for | immune-mediated disorders, Singapore NDF access and subcutaneous administration | biologic therapy, chronic inflammation management and subcutaneous injection | government subsidy eligibility, rheumatoid arthritis, high-concentration formulation and standard drug list access |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Hulio from Viatris / Fujifilm Kyowa Kirin Biologics."
I picked this because A formulary-listed biosimilar providing a standard dosage option in Singapore.
Share this search
Related Finds